Please ensure Javascript is enabled for purposes of website accessibility

Cerner Corporation's Q4 Exclamation Point and 2016 Question Mark

By Keith Speights - Feb 17, 2016 at 11:18AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Great Q4 results for the healthcare technology provider, but weaker-than-expected bookings guidance raises eyebrows.

Cerner Headquarters. Image source: Cerner

Things were looking up for Cerner Corporation (CERN) headed into the fourth quarter. Bookings, which reflect new contracts won but not yet recognized as revenue, hit an all-time high. Expectations were for a solid finish to the end of 2015. Cerner announced its fourth-quarter results after the market closed on Tuesday. The company capped off 2015 with an exclamation point -- but there's a question mark now for this year.

Cerner results: The raw numbers


Q4 2015 Actuals

Q4 2014 Actuals

Growth (YOY)


$1.175 billion

$926 million


Net Income From Continuing Operations

$166.1 million

$147.9 million


GAAP Earnings Per Share




Data source: Cerner.

What happened with Cerner this quarter?
Those numbers met or exceeded the expectations that Cerner set around three months ago. Fourth-quarter sales were right in the middle of the range that the healthcare technology provider gave in November. Cerner's adjusted earnings of $0.61 per share easily beat the per-share range of $0.56-$0.58 provided earlier. Other highlights from the fourth quarter and full-year 2015 included:

  • Bookings for the fourth quarter increased 16% year over year to $1.35 billion.
  • Full-year bookings reached an all-time high of $5.43 billion.
  • Fourth-quarter operating cash flow topped $353 million, with full-year operating cash flow of $947.5 million.
  • Total contract backlog jumped 34% year over year to $14.2 billion.

Cerner continued to grow its system sales at a strong pace -- up over 36% from the fourth quarter of 2014. Revenue from support, maintenance, and services also rose over 24% year over year.

Operating expenses, however, increased nearly 37%. While higher acquisition-related amortization expenses jumped significantly, Cerner also saw every other expense category increase by at least 30%.     

What management had to say
Zane Burke, Cerner's president, underscored his company's success in the fourth quarter and throughout 2015. Burke said:

Our fourth quarter results reflect a solid finish to a record year. In 2015, we added more than double the number of new EHR clients than any year in our history, including both large health systems and small hospitals. We also continued to advance our cloud-based HealtheIntent platform and had a very strong year of selling our population health solutions both inside and outside our EHR installed base.

Looking forward
With strong double-digit percentage gains on both the top and bottom lines, you might expect investors to be happy with Cerner's performance. However, its stock plunged as much as 16% in after-hours trading following Cerner's announcement of fourth-quarter results. What gives?

Cerner expects first-quarter 2016 revenue between $1.15 billion and $1.2 billion. Adjusted earnings per share for the quarter are projected to come in between $0.52 and $0.54. It expects full-year 2016 revenue of $4.9 billion to $5.1 billion and adjusted earnings per share (before share-based compensation expense and acquisition-related adjustments) between $2.30 and $2.40. All of those are right in line with the consensus of Wall Street analysts.

The problem stems from Cerner's forward guidance on bookings. New business bookings for first quarter are projected to come between $1.15 billion and $1.25 billion. That's slower than the last two sequential quarters and seems to have worried some investors.

There's no doubt that Cerner is facing plenty of competition. In the past, the company faced off frequently with privately-held Epic. Now, however, Cerner also must battle up-and-coming rival athenahealth (ATHN)

Athenahealth's success story so far has been primarily in the physician market. But the company recently landed its first contract with a major hospital, the University of Toledo Medical Center. What's more, athenahealth leveraged its prior relationship with the hospital's physician clinics to win the hospital contract.

Athenahealth CEO Jonathan Bush has stated in the past that he expects Cerner and Epic to "collapse like big black swans." It's definitely a huge overreaction to use Cerner's sluggish bookings forecast to claim that Bush's prediction is coming true. However, investors in the hospital EHR space will definitely want to closely watch the changing competitive dynamics in the industry in the months and years ahead.


Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Athenahealth and Cerner. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cerner Corporation Stock Quote
Cerner Corporation
athenahealth, Inc. Stock Quote
athenahealth, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/07/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.